title: Protective effect of zinc aspartate on long-term ischemia-reperfusion injury in rat skeletal muscle.
abstract: The present study investigated the protective effect of zinc aspartate, in connection with reactive oxygen species and nitric oxide, on long-term ischemia-reperfusion injury (IRI) in rat skeletal muscle. Following ketamine anesthesia, 24 rats were randomly assigned to four groups: groups 1 and 2, each without tourniquet application, received no drug and zinc, respectively; groups 3 and 4, each subjected to tourniquet-induced IRI (3 + 24 h), received no drug and zinc, respectively. IRI was achieved by the application of an elastic rubber band in the left hind limb of the anesthetized rats. Gastrocnemius muscle samples were obtained for biochemical measurements. Malondialdehyde levels were lower in group 2 and higher in group 3 than those seen in group 1. However, zinc aspartate (group 4) totally reversed malondialdehyde levels to control levels. Superoxide dismutase activity was increased in group 2 compared with group 1; however, there was no difference between groups 1 and 3, and Zn injection (group 4) increased superoxide dismutase activity. While catalase values were similar in groups 1 and 2, significant increments were observed in 3 and 4. A similar enhancement in glutathione levels were observed in groups 2 and 4 compared with group 1. Nitric oxide levels were lower in group 2 than 1, and no difference between groups 1 and 3 was demonstrated. In conclusion, zinc seems to be an effective treatment option against IRI.
authors: Department of Cardiovascular Surgery, School of Medicine, Cumhuriyet University, Sivas, Turkey.
authors: Erhan
authors: E
authors: Atahan
authors: Yusuf
authors: Y
authors: Ergün
authors: Ergül Belge
authors: EB
authors: Kurutaş
authors: Tuğrul
authors: T
authors: Alici
mesh_terms: D000818:Animals; D001224:Aspartic Acid / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D002374:Catalase / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009569:Nitric Oxide / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D015427:Reperfusion Injury / Q000188:drug therapy / Q000473:pathology; D013482:Superoxide Dismutase / Q000378:metabolism; D017967:Zinc Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D017382:Reactive Oxygen Species; D017967:Zinc Compounds; D001224:Aspartic Acid; D009569:Nitric Oxide; D008315:Malondialdehyde; D002374:Catalase; D013482:Superoxide Dismutase; D005978:Glutathione